Heart drugs under study focus on impact on metabolism

Article

Some help for battling the obesity epidemic may be arriving, according to continuing encouraging results for rimonabant (Acomplia, Sanofi-Aventis), not just in helping weight loss but also in improving metabolic risk factors. Other research at this year's American Heart Association 2004 Scientific Sessions, held recently in New Orleans, focused, as well, on metabolic effects of pharmacological agents.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Related Content
Collaborative Care Approaches Can Improve Provider Shortage, Pharmacist-Physician Relationships | ACCP 2024

Collaborative Care Approaches Can Improve Provider Shortage, Pharmacist-Physician Relationships | ACCP 2024

Brian Nowosielski
October 17th 2024
Article

In posters presented at the American College of Clinical Pharmacy 2024 Annual Meeting, researchers explored the implementation of collaborative care programs within various health systems.

pharmacist and patient

Reach Your Business Goals in 2021

Jennifer Barrett
March 25th 2021
Podcast

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

Pharmacists’ Ability to Close Gap in Delivery of Oral Anticoagulation Therapy

Pharmacists’ Ability to Close Gap in Delivery of Oral Anticoagulation Therapy

Brian Nowosielski
August 2nd 2024
Article

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Over the Counter podcast

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021
Podcast

Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.

Workplace Flexibility Could Increase Quality of Life, Productivity for Pharmacy Employees

Workplace Flexibility Could Increase Quality of Life, Productivity for Pharmacy Employees

Killian Meara
Published: June 19th 2024 | Updated: June 19th 2024
Article

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Brian Nowosielski
June 14th 2024
Article

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

© 2024 MJH Life Sciences

All rights reserved.